Comparative study of duloxetine and citalopram in the treatment of senile depresson
Xie Ru
Abstract
Xie Ru
Abstract
Objective To compare clinical efficacy and safety of between duloxetine and citalopram in the treatment of senile depression.Methods 29 patients were randomly divided into duloxetine group(n=29) and citalopram group(n=29) for 8 weeks.Hamilton rating scale for depression(HAMD)、Hamilton rating scale for anxiety(HAMA) and treatment emergent symtom scale(TESS)were used to evaluate the efficacy and side effects respectively.Results There were no significant difference in efficacy at the end of 8th weeks(P0.05) between 2 groups.There were no significant difference in side effect between these two groups.Conclusion Duloxetine is an safe and effecfive antidepressant in the treatment of senile depression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare clinical efficacy and safety of between duloxetine and citalopram in the treatment of senile depression.Methods 29 patients were randomly divided into duloxetine group(n=29) and citalopram group(n=29) for 8 weeks.Hamilton rating scale for depression(HAMD)、Hamilton rating scale for anxiety(HAMA) and treatment emergent symtom scale(TESS)were used to evaluate the efficacy and side effects respectively.Results There were no significant difference in efficacy at the end of 8th weeks(P0.05) between 2 groups.There were no significant difference in side effect between these two groups.Conclusion Duloxetine is an safe and effecfive antidepressant in the treatment of senile depression.
Key concepts: Duloxetine, Hamd, Citalopram, Rating scale, Antidepressant, Depression (economics), Escitalopram, Psychology